Commercial Operations & Intelligence Systems — Frontier Health

The operating intelligence beneath the next era of human health.

Breakthroughs in human health rarely fail on the science. They fail on execution — the U.S. entry that stalls, the commercial engine that never gets built, the field teams that never become one. OmniTyx builds the operational and intelligence layer that carries the science into the real world — and makes it hold.

The science earns the headline. The operation decides whether it survives.

// What gets built

Operating judgment, not advice from the sidelines.

Four disciplines, run as one system — built, owned, and accountable to the number.

U.S. Market Entry & Expansion

Most companies enter the U.S. twice before it works. This time it worked once.

Rebuilt a global company's U.S. entry from zero after two failed attempts — and the revenue followed. Entry isn't a slide deck; it's a hundred decisions made in the right order, under pressure, with no margin for the wrong one.

Go-to-Market & Revenue Operations

The commercial engine, engineered to compound.

How an organization finds real demand, proves value to skeptical buyers, and turns clinical credibility into revenue that compounds instead of stalling — pipeline, motion, and the operating cadence underneath it.

Distributed Teams, On the Ground

Field teams run as a single front, not scattered headcount.

Distributed teams across healthcare, sales, and tech — hired, structured, and coordinated into one operating front. In regulated, relationship-driven markets, coordination is the product.

AI-Integrated Operations

Intelligence across the full client lifecycle.

Automation and decision intelligence woven through the entire lifecycle, so the organization sees more, decides faster, and spends its people only on the work that genuinely demands a human.

Operating index  //  Decision Intelligence · Operations Infrastructure · System Architecture · Business Systems Design · Automation Strategy

// Track record

$9M+

in revenue driven selling complex clinical technology into regulated, relationship-driven markets — where trust is earned slowly and a single detail can end the deal.

// Where this leads

The next problems worth solving are the hardest ones.

The frontier of human health runs through its most unforgiving terrain — cryomedicine, regenerative medicine, the infrastructure of extending healthy life. Most operators route around it: too slow, too regulated, too high-stakes. That's precisely the draw. These missions don't need another advisor — they need someone who will own the operation and carry it.

I'm best where ownership is real, the scope compounds, and the mission actually matters.